PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 11, 1989New England Journal of Medicine68 citations

Autoimmune Hyperchylomicronemia

View Full Paper
SKShinji KiharaYMYūji MatsuzawaMKMasaharu Kubo

Key Points

Key points are not available for this paper at this time.

Abstract

AMONG the hyperchylomicronemias, familial deficiencies of lipoprotein lipase (LPL) and of apolipoprotein C-II are rare variants in which the underlying biochemical defects are relatively well defined. The diseases are characterized by a deficiency of LPL, which is the key enzyme in the hydrolysis of triglyceride-rich lipoproteins, or a defect in apolipoprotein C-II, a cofactor of LPL.1 2 3 4 Hyperchylomicronemia may also be a primary characteristic of type V familial hyperlipoproteinemia,5 or it may be secondary to a variety of conditions, such as diabetes mellitus, alcoholism, chronic renal failure, or hypothyroidism.6 7 8 9 10 11 The mechanism of secondary hyperchylomicronemia has not been fully elucidated.We describe . . .

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kihara et al. (1989) studied this question.

synapsesocial.com/papers/6a706378660549caf2c4f6d2https://doi.org/10.1056/nejm198905113201906
Ask AI
Helpful
Bookmark
Share
View Full Paper